Interestingly, our analysis of microarray data from lesional and non-lesional skin of patients with AD revealed that the gene expression of IGFBP-5, the parent protein of AMP-IBP5, is downregulated in AD skin lesions (Figure 4A). This evidence concerns the gene IGFBP5 and Alzheimer disease.